Skip to main content
SpringerLink
Log in

Plasma Clusterin Increased Prior to Small for Gestational Age (SGA) Associated With Preeclampsia and Decreased Prior to SGA in Normotensive Pregnancies

  • Original Articles
  • Published:
Reproductive Sciences Aims and scope Submit manuscript

Abstract

In our search for early biomarkers for the pregnancy complicationssmall for gestational age (SGA) and preeclampsia (PE) we analysed plasma from 19-21 weeks gestation in women recruited into the SCOPE study, a prospective cohort of nulliparous women, by differential in gel electrophoresis (DIGE). DIGE revealed the differential expression of clusterin levels and its isoforms in top6-depleted plasma of women who delivered an SGA infant but remained normotensive (SGA-NT; N = 8) compared to healthy women with an uncomplicated pregnancy outcome (Controls, N = 8). Immunosorbent enzyme-linked assay (ELISA) showed that compared to plasma clusterin levels from healthy controls [71.1 (SD 12.4) µg/mL, n = 39], clusterin was decreased in SGA-NT [58.3 (SD 11.7), N = 20, P < 0.0001], increased in women with SGA and PE [81.5 (SD 14.8), N = 20, P < 0.01], but similar in PE alone [71.2 (SD 9.4)g/ml, P = 1.0]. Screening for clusterin levels and/or its different isoformsmay be useful in mid-pregnancy to identify women who subsequently develop SGA but remain normotensive or who develop preeclampsia with SGA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. McCormick MC. The contribution of low birth weight to infant mortality and childhood morbidity. N Engl J Med. 1985;312(2): 82–90.

    Article  CAS  Google Scholar 

  2. McCowan LME, Roberts CT, Dekker GA, et al; SCOPE consortium. Risk factors for small-for-gestational-age infants by customized birthweight centiles: data from an international prospective cohort study. Br J Obstet Gynaecol. 2010;117(13): 1599–1607.

    Article  CAS  Google Scholar 

  3. Groom KM, North RA, Poppe KK, Sadler L, McCowan LM. The association between customized small for gestational age infants and pre-eclampsia or gestational hypertension varies with gestation at delivery. Br J Obstet Gynaecol. 2007;114(4): 478–484.

    Article  CAS  Google Scholar 

  4. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005;308(5728): 1592–1594.

    Article  CAS  Google Scholar 

  5. Ness RB, Sibai BM. Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am J Obstet Gynecol. 2006;195(1): 40–49.

    Article  Google Scholar 

  6. Shankar R, Gude N, Cullinane F, Brennecke S, Purcell AW, Moses EK. An emerging role for comprehensive proteome analysis in human pregnancy research. Reproduction. 2005;129(6): 685–696.

    Article  CAS  Google Scholar 

  7. Blumenstein M, McMaster MT, Black MA, et al. A proteomic approach identifies early pregnancy biomarkers for preeclampsia: novel linkages between a predisposition to preeclampsia and cardiovascular disease. Proteomics. 2009;9(11): 2929–2945.

    Article  CAS  Google Scholar 

  8. Watanabe H, Hamada H, Yamada N, et al. Proteome analysis reveals elevated serum levels of clusterin in patients with preeclampsia. Proteomics. 2004;4(2): 537–543.

    Article  CAS  Google Scholar 

  9. Blankley RT, Gaskell SJ, Whetton AD, Dive C, Baker PN, Myers JE. A proof-of-principle gel-free proteomics strategy for the identification of predictive biomarkers for the onset of pre-eclampsia. Br J Obstet Gynaecol. 2009;116(11): 1473–1480.

    Article  CAS  Google Scholar 

  10. Auer J, Camoin L, Guillonneau F, et al. Serum profile in preeclampsia and intra-uterine growth restriction revealed by iTRAQ technology. J Proteomics. 2010;73(5): 1004–1017.

    Article  CAS  Google Scholar 

  11. Jenne DE, Tschopp J. Clusterin: the intriguing guises of a widely expressed glycoprotein. Trends Biochem Sci. 1992;17(4): 154–159.

    Article  CAS  Google Scholar 

  12. McCowan L, North R, Taylor R. ACTRN12607000551493. Australian New Zealand Clinical Trials Registry, 2007. http://www.anzctr.org.au/trialSearch.aspx.

  13. Gardosi J, Mongelli M, Wilcox M, Chang A. An adjustable fetal weight standard. Ultrasound Obstet Gynecol. 1995;6(3): 168–174.

    Article  CAS  Google Scholar 

  14. North RA, McCowan LM, Dekker GA, et al. Clinical risk prediction for pre-eclampsia in nulliparous women: development of model in international prospective cohort. BMJ. 2011; 342: d1875.

    Article  Google Scholar 

  15. Shin JK, Han KA, Kang MY, et al. Expression of clusterin in normal and preeclamptic placentas. J Obstet Gynaecol Res. 2008;34(4): 473–479.

    Article  CAS  Google Scholar 

  16. Witte DP, Aronow BJ, Stauderman ML, et al. Platelet activation releases megakaryocyte-synthesized apolipoprotein J, a highly abundant protein in atheromatous lesions. Am J Pathol. 1993;143(3): 763–773.

    PubMed  PubMed Central  CAS  Google Scholar 

  17. Chen M, Yuan Z, Shan K. Association of apolipoprotein J gene 866C–>T polymorphism with preeclampsia and essential hypertension. Gynecol Obstet Invest. 2005;60(3): 133–138.

    Article  CAS  Google Scholar 

  18. Bartl MM, Luckenbach T, Bergner O, Ullrich O, Koch-Brandt C. Multiple receptors mediate apoJ-dependent clearance of cellular debris into nonprofessional phagocytes. Exp Cell Res. 2001;271(1): 130–141.

    Article  CAS  Google Scholar 

  19. Santilli G, Aronow BJ, Sala A. Essential requirement of apolipoprotein J (clusterin) signaling for IkappaB expression and regulation of NF-kappaB activity. J Biol Chem. 2003;278(40): 38214–38219.

    Article  CAS  Google Scholar 

  20. Schwarz M, Spath L, Lux CA, et al. Potential protective role of apoprotein J (clusterin) in atherogenesis: binding to enzymatically modified low-density lipoprotein reduces fatty acid-mediated cytotoxicity. Thromb Haemost. 2008;100(1): 110–118.

    PubMed  CAS  Google Scholar 

  21. Sivamurthy N, Stone DH, Logerfo FW, Quist WC. Apolipoprotein J inhibits the migration, adhesion, and proliferation of vascular smooth muscle cells. J Vasc Surg. 2001;34(4): 716–723.

    Article  CAS  Google Scholar 

  22. Trougakos IP, Djeu JY, Gonos ES, Boothman DA. Advances and challenges in basic and translational research on clusterin. Cancer Res. 2009;69(2): 403–406.

    Article  CAS  Google Scholar 

  23. Kapron JT, Hilliard GM, Lakins JN, et al. Identification and characterization of glycosylation sites in human serum clusterin. Protein Sci. 1997;6(10): 2120–2133.

    Article  CAS  Google Scholar 

  24. Cochrane DR, Wang Z, Muramaki M, Gleave ME, Nelson CC. Differential regulation of clusterin and its isoforms by androgens in prostate cells. J Biol Chem. 2007;282(4): 2278–2287.

    Article  CAS  Google Scholar 

  25. Hellebrekers DM, Melotte V, Vire E, et al. Identification of epigenetically silenced genes in tumor endothelial cells. Cancer Res. 2007;67(9): 4138–4148.

    Article  CAS  Google Scholar 

  26. Jackson JK, Gleave ME, Gleave J, Burt HM. The inhibition of angiogenesis by antisense oligonucleotides to clusterin. Angiogenesis. 2005;8(3): 229–238.

    Article  CAS  Google Scholar 

  27. Stewart EM, Aquilina JA, Easterbrook-Smith SB, et al. Effects of glycosylation on the structure and function of the extracellular chaperone clusterin. Biochemistry. 2007;46(5): 1412–1422.

    Article  CAS  Google Scholar 

  28. Arkwright PD, Redman CW, Williams PJ, Dwek RA, Rademacher TW. Syncytiotrophoblast membrane protein glycosylation patterns in normal human pregnancy and changes with gestational age and parturition. Placenta. 1991;12(6): 637–651.

    Article  CAS  Google Scholar 

  29. Karamessinis PM, Malamitsi-Puchner A, Boutsikou T, et al. Marked defects in the expression and glycosylation of alpha2-HS glycoprotein/fetuin-A in plasma from neonates with intrauterine growth restriction: proteomics screening and potential clinical implications. Mol Cell Proteomics. 2008;7(3): 591–599.

    Article  CAS  Google Scholar 

  30. Rodriguez-Pineiro AM, de la Cadena MP, Lopez-Saco A, Rodriguez-Berrocal FJ. Differential expression of serum clusterin isoforms in colorectal cancer. Mol Cell Proteomics. 2006;5(9): 1647–1657.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Biological Sciences, Faculty of Science, University of Auckland, Auckland, New Zealand

    Marion Blumenstein PhD, Steven Wu PhD & Garth J. S. Cooper MBCHB, Dphil

  2. Department of Obstetrics & Gynecology, Faculty of Medical & Health Sciences, University of Auckland, Auckland, New Zealand

    Lesley M. E. McCowan MBChB, PhD & Robyn A. North MBCHB, PhD

  3. Centre for Advanced Discovery and Experimental Therapeutics (CADET), School of Biomedicine, The University of Manchester, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK

    Garth J. S. Cooper MBCHB, Dphil

  4. Maurice Wilkins Centre for Biodiscovery, Faculty of Science, University of Auckland, Auckland, New Zealand

    Garth J. S. Cooper MBCHB, Dphil

  5. Division of Women’s Health, King’s College London, UK

    Robyn A. North MBCHB, PhD

  6. University of Auckland, Kate Edger Information Commons, 11 Symonds Street Private Bag 92019, Auckland, 1142, New Zealand

    Marion Blumenstein PhD

Authors
  1. Marion Blumenstein PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lesley M. E. McCowan MBChB, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Steven Wu PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Garth J. S. Cooper MBCHB, Dphil
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Robyn A. North MBCHB, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

on behalf of the SCOPE consortium

Corresponding author

Correspondence to Marion Blumenstein PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Blumenstein, M., McCowan, L.M.E., Wu, S. et al. Plasma Clusterin Increased Prior to Small for Gestational Age (SGA) Associated With Preeclampsia and Decreased Prior to SGA in Normotensive Pregnancies. Reprod. Sci. 19, 650–657 (2012). https://doi.org/10.1177/1933719111430999

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/1933719111430999

Keywords

Search

Navigation